Skip to main content
. 2022 Aug 10;13:909948. doi: 10.3389/fphar.2022.909948

TABLE 1.

CDD for medications administered orally for selected indications.

Indication Medicine Common daily dose (CDD) for the indication
Non-small-cell lung cancer (NSCL) Afatinib 40 mg/day
Alectinib 1,200 mg/day
Ceritinib 750 mg/day
Crizotinib 500 mg/day
Erlotinib 150 mg/day
Gefitinib 250 mg/day
Osimertinib 80 mg/day
Chronic myeloid leukemia (CML) Dasatinib 100 mg/day
Imatinib 400 mg/day
Nilotinib 600 mg/day
Ponatinib 45 mg/day
Breast cancer (BC) Tamoxifen 20 mg/day
Letrozole 2.5 mg/day
Anastrazole 1 mg/day
Exemestan 25 mg/day
Palbociclib 125 mg/day
Ribociclib 600 mg/day
Abemaciclib 300 mg/day